• Molecular NameMizolastine
  • SynonymNA
  • Weight432.503
  • Drugbank_IDN/A
  • ACS_NO108612-45-9
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.1
  • pkaN/A
  • LogD (pH=7, predicted)2.64
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.71
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors1
  • No.of HBond Acceptors7
  • No.of Rotatable Bonds5
  • TPSA65.76
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA once daily, non-sedating antihistamine.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability65.0
  • Protein binding98.4
  • Volume of distribution (VD)1.4 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life13 h In patients with hepatic impairment, 15.1 h and renal impairment 19.2 h.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A